Recurrent involvement of the REL and BCL11A loci in classical Hodgkin lymphoma.
about
Functional studies of BCL11A: characterization of the conserved BCL11A-XL splice variant and its interaction with BCL6 in nuclear paraspeckles of germinal center B cellsClinical and molecular cytogenetic characterisation of a newly recognised microdeletion syndrome involving 2p15-16.1c-Rel and its many roles in cancer: an old story with new twistsUnexpected functions of nuclear factor-κB during germinal center B-cell development: implications for lymphomagenesisThyroid nodule as a first manifestation of Hodgkin lymphoma-report of two cases and literature reviewSWI/SNF chromatin remodeling complexes and cancerThe c-Rel transcription factor and B-cell proliferation: a deal with the devilA genome-wide association study of Hodgkin's lymphoma identifies new susceptibility loci at 2p16.1 (REL), 8q24.21 and 10p14 (GATA3)Single agent bortezomib in the treatment of relapsed and refractory Hodgkin lymphoma: cancer and leukemia Group B protocol 50206.Human population-specific gene expression and transcriptional network modification with polymorphic transposable elements.Pathobiology of hodgkin lymphoma.Molecular karyotypes of Hodgkin and Reed-Sternberg cells at disease onset reveal distinct copy number alterations in chemosensitive versus refractory Hodgkin lymphomaPathogenetic importance and therapeutic implications of NF-κB in lymphoid malignancies.A critical role for the NFkB pathway in multiple myeloma.Hodgkin's Lymphomas: A Tumor Recognized by Its Microenvironment.Inactivating I kappa B epsilon mutations in Hodgkin/Reed-Sternberg cells.Molecular biology of Hodgkin's and Reed/Sternberg cells in Hodgkin's lymphoma.Clinical, pathological and genetic features of primary mediastinal large B-cell lymphomas and mediastinal gray zone lymphomas in children.EBV in Hodgkin Lymphoma.Epstein-Barr virus infection in humans: from harmless to life endangering virus-lymphocyte interactions.The molecular pathogenesis of Hodgkin lymphoma.Hodgkin lymphoma.The c-Rel Transcription Factor in Development and Disease.Aberrant expression of ID2, a suppressor of B-cell-specific gene expression, in Hodgkin's lymphoma.Aberrantly Expressed OTX Homeobox Genes Deregulate B-Cell Differentiation in Hodgkin Lymphoma.Mechanisms of B-cell lymphoma pathogenesis.Hodgkin lymphoma requires stabilized NIK and constitutive RelB expression for survivalAberrant expression of homeobox gene SIX1 in Hodgkin lymphoma.The NF-κB subunit c-Rel regulates Bach2 tumour suppressor expression in B-cell lymphomaBCL11A overexpression predicts survival and relapse in non-small cell lung cancer and is modulated by microRNA-30a and gene amplification.Contribution of the Epstein Barr virus to the molecular pathogenesis of Hodgkin lymphoma.A retroviral mutagenesis screen reveals strong cooperation between Bcl11a overexpression and loss of the Nf1 tumor suppressor gene.Downregulation of BCL11A by siRNA induces apoptosis in B lymphoma cell lines.Mechanisms and consequences of constitutive NF-κB activation in B-cell lymphoid malignancies.Modes of infection and oncogenesis by the Epstein-Barr virus.Structural genomic alterations in primary mediastinal large B-cell lymphoma.Molecular cytogenetic detection of chromosomal breakpoints in T-cell receptor gene loci.Hodgkin's lymphoma cell lines are characterized by frequent aberrations on chromosomes 2p and 9p including REL and JAK2.An update on genomic-guided therapies for pediatric solid tumors.Detection and prognostic value of recurrent exportin 1 mutations in tumor and cell-free circulating DNA of patients with classical Hodgkin lymphoma.
P2860
Q21093284-0AC34956-438A-4C16-BB3D-4587A185000CQ24647937-370B943E-BE0A-4221-B4CD-5D700BD9BED6Q26772234-47CB7784-71E5-40BB-A37C-16400CB41F31Q26822486-16D7036A-C10A-429E-A9CC-804160620E09Q26862783-4BF014A9-A69E-41C2-A56B-390E27924948Q26998657-9E44EC69-36DA-453E-9656-0681329002DFQ28241767-D7AF721A-ACAE-4045-8028-3F7439ADACE5Q28943455-B7D1970E-D666-41C8-8303-A73B6AFCCE7EQ33375800-FC064BE1-277F-4606-933F-F7072A888F51Q33558432-3173557B-17CE-4EC0-B4DA-13FE230D3822Q33778402-D4E5043C-64F4-4957-BB06-0F8674F278ECQ33840504-EDBA955A-2860-43E3-8F3C-78CC0193C581Q33889168-956BDD5B-1BE4-4D05-984B-E9AACE931A7BQ34165181-8C035020-8B13-47CF-88AB-4CDFED299E89Q34235750-E3F0574A-B5D2-48F8-9DC2-7F034C1C6016Q34274124-00BC0171-8F71-44C9-A0F6-0FBDC77F55CAQ34480682-7847DC75-661A-4D43-BB5C-7036B0B1FA20Q34543027-C2074A98-83AF-44A5-90CC-679B7B79B395Q34549468-10B5361E-1EB4-426C-A2BD-8FFC51777160Q34576340-EFA0F5DB-7228-4126-A454-B37E93C209BEQ34626576-E21E107C-42DB-4E39-8A9B-E8755D4D18B9Q34643277-83DDEC6C-E10A-408D-8909-73F3728B8D0CQ35556506-143162EB-7E32-47CF-920A-5A65BBB5894DQ35607200-D32DFC3B-A497-4B5E-8B91-AE556492C745Q35788374-8765AE2D-DC49-4E70-AD84-7267F8E1A866Q36085626-B83C7D15-B2B9-434C-A58F-A1B41D247F44Q36370847-EAD0C5A9-BC3E-4EEC-8060-407577312468Q36545556-B130FF9C-9272-4EC1-A292-D8C501BCD6FBQ36858771-75AF76D2-CC23-484B-B4A2-A1525CC960EBQ36964364-6A351236-B13B-4A62-A1D5-12E854155B8BQ37016499-C601FAB4-1EF0-44E5-A9A8-745975A52B01Q37081986-FF6C8120-BA46-4190-B743-5CA532DDB085Q37641982-F9A47453-CAF1-4A94-B048-DC7A6A8F103BQ38182355-2F1748E0-3645-47F6-82D4-94852EFE33F3Q38191876-C03412DB-E388-4303-96B2-D2B1A6C535E7Q38267888-98DA738A-DDA0-4B6F-BA00-70BDBB24A03AQ38484538-7DCD13A1-5D17-4DE4-871C-8AC681A68929Q38486378-29DFAB87-4E06-4F37-8B82-820ADF405E2FQ38673827-8F38FE17-1CDF-46FB-8F57-B09C2ADF61EEQ38754419-F2611F25-6FEE-4C92-BD1A-1D85C1D44BD1
P2860
Recurrent involvement of the REL and BCL11A loci in classical Hodgkin lymphoma.
description
2002 nî lūn-bûn
@nan
2002 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Recurrent involvement of the REL and BCL11A loci in classical Hodgkin lymphoma.
@ast
Recurrent involvement of the REL and BCL11A loci in classical Hodgkin lymphoma.
@en
Recurrent involvement of the REL and BCL11A loci in classical Hodgkin lymphoma.
@nl
type
label
Recurrent involvement of the REL and BCL11A loci in classical Hodgkin lymphoma.
@ast
Recurrent involvement of the REL and BCL11A loci in classical Hodgkin lymphoma.
@en
Recurrent involvement of the REL and BCL11A loci in classical Hodgkin lymphoma.
@nl
prefLabel
Recurrent involvement of the REL and BCL11A loci in classical Hodgkin lymphoma.
@ast
Recurrent involvement of the REL and BCL11A loci in classical Hodgkin lymphoma.
@en
Recurrent involvement of the REL and BCL11A loci in classical Hodgkin lymphoma.
@nl
P2093
P50
P356
P1433
P1476
Recurrent involvement of the REL and BCL11A loci in classical Hodgkin lymphoma
@en
P2093
Brigitte Schlegelberger
Lana Harder
Martin L Hansmann
Philip W Tucker
Stefan Gesk
Takashi Sonoki
Werner Grote
P304
P356
10.1182/BLOOD.V99.4.1474
P407
P577
2002-02-01T00:00:00Z